EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin

Sivakumar Jeyarajan, Sukumar Ranjith, Atchyasri Anbarasu, Indira Kandasamy, Prahalathan Chidambaram, Anbarasu Kumarasamy

Medical Oncology · 22.07.2026 · 43 (9)

DOI: 10.1007/s12032-026-03344-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 22.07.2026. Verfasst von Sivakumar Jeyarajan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. jeyaraja@umich.…. Hauptthemen laut MEDLINE: Doxorubicin, Antimicrobial Cationic Peptides, Antineoplastic Agents, Amphibian Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we evaluated the in silico and in vitro anticancer activity of the antimicrobial peptide epinecidin-1 (Epi-1) and its lysine-substituted variants (Variant-1 (Var-1) & Variant-2 (Var-2)). Computational docking demonstrated energetically favourable and structurally consistent interactions between the peptides and cancer-associated receptors (MerTK (PDB ID: 7OLX), EphA3 (PDB ID: 2QO9), TGF-β receptor I/ ALK5 (PDB ID: 3TZM), TrkA / NTRK1 (PDB ID: 4AOJ), and progesterone receptor (PDB ID: 1A28)), with distinct binding orientations and interaction profiles observed across the variants. Molecular dynamics simulation further substantiated these findings by confirming the stability of the selected receptor-ligand complex, with consistent root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), and intermolecular hydrogen-bond interactions profiles indicating sustained interaction integrity under dynamic conditions. The in vitro antiproliferative activity of Epi-1 and its variants was assessed by MTT assays against A549, HeLa, HepG2, IMR-32 and MCF-7 cell lines. Both variants exhibited a two- to four-fold increase in cytotoxic activity compared with native Epi-1. We also evaluated the combinational activity of each peptide with doxorubicin, where peptide-doxorubicin treatments resulted in effective cancer cell killing at reduced drug concentrations relative to individual treatments, the Var-2 + doxorubicin combination reduced cancer cell survival to below 10% at a combined concentration of 1 µg/mL (0.5 µg/mL peptide + 0.5 µg/mL doxorubicin), compared with ~ 30% survival in doxorubicin alone. This has been added alongside the existing two- to four-fold cytotoxicity enhancement of the variants over wild-type Epi-1, to better convey the impact of the synergistic response. While inducing selective lysis in cancer cells, the peptides exhibited minimal cytotoxicity toward non-cancerous HEK 293 cells, indicating improved therapeutic selectivity. DCFH-DA staining confirmed intracellular reactive oxygen species generation, and Acridine Orange/Ethidium Bromide (AO/EtBr) staining demonstrated apoptosis as the predominant mode of cell death across the cancer cell lines, although Var-1 induced necrotic death in HepG2 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinAntimicrobial Cationic PeptidesAntineoplastic AgentsAmphibian ProteinsAntineoplastic Combined Chemotherapy ProtocolsHumansCell ProliferationMolecular Docking SimulationMolecular Dynamics SimulationCell Line, TumorApoptosisFish Proteins

Stichwörter der Autor:innen

AnticancerAntimicrobial peptidesDoxorubicinEpinecidin-1Variants

Substanzen

DoxorubicinAntimicrobial Cationic Peptidesepinecidin-1, Epinephelus coioidesAntineoplastic AgentsAmphibian ProteinsFish Proteins

Autor:innen und Institutionen

  • Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. jeyaraja@umich.edu.
  • Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA. jeyaraja@umich.edu.
  • Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
  • Swamy Vivekananda Medical College Hospital and Research Institute, Tiruchengode, 637205, Tamil Nadu, India.
  • Department of Biochemistry, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
  • Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. anbumbt@bdu.ac.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Jeyarajan, S., Ranjith, S., Anbarasu, A., Kandasamy, I., Chidambaram, P., & Kumarasamy, A. (2026). Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin. Medical Oncology, 43(9). https://doi.org/10.1007/s12032-026-03344-0

Vancouver

Jeyarajan S, Ranjith S, Anbarasu A, Kandasamy I, Chidambaram P, Kumarasamy A. Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin. Medical Oncology. 2026;43(9). doi:10.1007/s12032-026-03344-0

BibTeX
@article{Jeyarajan2026,
  author = {Jeyarajan, Sivakumar and Ranjith, Sukumar and Anbarasu, Atchyasri and Kandasamy, Indira and Chidambaram, Prahalathan and Kumarasamy, Anbarasu},
  title = {Anticancer effects of alpha-helical peptide epinecidin-1 and its variants in combination with doxorubicin},
  journal = {Medical Oncology},
  year = {2026},
  volume = {43},
  number = {9},
  doi = {10.1007/s12032-026-03344-0}
}
Kostenlos starten →